Hoffmann, J.H. et al. 2017. Routine Laboratory Parameter Dynamics and Laboratory Adverse Events in Psoriasis Patients on Long-term Treatment with Adalimumab, Etanercept, and Ustekinumab. Acta Dermato-Venereologica. 97, 6 (Mar. 2017), 705–710. DOI:https://doi.org/10.2340/00015555-2644.